Guizhou Bailing Group Pharmaceutical Co., Ltd. (002424.SZ)
CNY 4.06
(2.78%)
CNY 4.06
(2.78%)
| Year | Gross Profit | Gross Profit Growth |
|---|---|---|
| 2023 | 2.31 Billion CNY | 10.76% |
| 2022 | 2.12 Billion CNY | 14.71% |
| 2021 | 1.85 Billion CNY | 6.46% |
| 2020 | 1.74 Billion CNY | 1.69% |
| 2019 | 1.71 Billion CNY | -8.56% |
| 2018 | 1.87 Billion CNY | 14.29% |
| 2017 | 1.63 Billion CNY | 15.06% |
| 2016 | 1.42 Billion CNY | 20.94% |
| 2015 | 1.17 Billion CNY | 22.96% |
| 2014 | 958.46 Million CNY | 13.27% |
| 2013 | 846.19 Million CNY | 13.53% |
| 2012 | 745.36 Million CNY | 18.3% |
| 2011 | 630.09 Million CNY | 39.5% |
| 2010 | 451.67 Million CNY | 34.16% |
| 2009 | 336.65 Million CNY | 18.71% |
| 2008 | 283.58 Million CNY | 30.67% |
| 2007 | 217.02 Million CNY | 0.0% |
| Year | Gross Profit | Gross Profit Growth |
|---|---|---|
| 2024 Q3 | 313.48 Million CNY | -28.52% |
| 2024 Q2 | 438.53 Million CNY | -48.46% |
| 2024 Q1 | 850.83 Million CNY | 9.12% |
| 2023 Q4 | 779.72 Million CNY | 55.44% |
| 2023 FY | 2.35 Billion CNY | 10.76% |
| 2023 Q1 | 657.17 Million CNY | -21.3% |
| 2023 Q2 | 418.65 Million CNY | -36.29% |
| 2023 Q3 | 501.63 Million CNY | 19.82% |
| 2022 Q4 | 835.01 Million CNY | 59.57% |
| 2022 Q3 | 523.29 Million CNY | 50.85% |
| 2022 Q2 | 346.88 Million CNY | -18.0% |
| 2022 Q1 | 423.01 Million CNY | -34.3% |
| 2022 FY | 2.12 Billion CNY | 14.71% |
| 2021 Q2 | 341.87 Million CNY | -19.16% |
| 2021 Q3 | 446.68 Million CNY | 30.66% |
| 2021 Q1 | 422.89 Million CNY | -18.92% |
| 2021 FY | 1.85 Billion CNY | 6.46% |
| 2021 Q4 | 643.82 Million CNY | 44.13% |
| 2020 Q3 | 450.51 Million CNY | 32.51% |
| 2020 FY | 1.74 Billion CNY | 1.69% |
| 2020 Q1 | 430.71 Million CNY | 6.22% |
| 2020 Q2 | 339.98 Million CNY | -21.07% |
| 2020 Q4 | 521.54 Million CNY | 15.77% |
| 2019 Q2 | 399.65 Million CNY | -6.98% |
| 2019 FY | 1.71 Billion CNY | -8.56% |
| 2019 Q3 | 479.08 Million CNY | 19.87% |
| 2019 Q1 | 429.61 Million CNY | -31.5% |
| 2019 Q4 | 405.48 Million CNY | -15.36% |
| 2018 Q2 | 434.06 Million CNY | 9.19% |
| 2018 Q4 | 627.14 Million CNY | 50.96% |
| 2018 Q1 | 397.53 Million CNY | -23.41% |
| 2018 FY | 1.87 Billion CNY | 14.29% |
| 2018 Q3 | 415.44 Million CNY | -4.29% |
| 2017 Q4 | 519.05 Million CNY | 44.37% |
| 2017 FY | 1.63 Billion CNY | 15.06% |
| 2017 Q1 | 381.03 Million CNY | -17.31% |
| 2017 Q2 | 380.22 Million CNY | -0.21% |
| 2017 Q3 | 359.53 Million CNY | -5.44% |
| 2016 Q1 | 267.68 Million CNY | -35.41% |
| 2016 Q3 | 346.36 Million CNY | -1.16% |
| 2016 FY | 1.42 Billion CNY | 20.94% |
| 2016 Q2 | 350.41 Million CNY | 30.9% |
| 2016 Q4 | 460.79 Million CNY | 33.04% |
| 2015 Q4 | 414.46 Million CNY | 47.28% |
| 2015 FY | 1.17 Billion CNY | 22.96% |
| 2015 Q3 | 281.41 Million CNY | 9.92% |
| 2015 Q2 | 256.02 Million CNY | 12.97% |
| 2015 Q1 | 226.62 Million CNY | -34.07% |
| 2014 Q4 | 343.72 Million CNY | 64.09% |
| 2014 Q2 | 207.02 Million CNY | 4.43% |
| 2014 Q3 | 209.47 Million CNY | 1.18% |
| 2014 FY | 958.46 Million CNY | 13.27% |
| 2014 Q1 | 198.24 Million CNY | -34.31% |
| 2013 Q4 | 301.78 Million CNY | 81.53% |
| 2013 FY | 846.19 Million CNY | 13.53% |
| 2013 Q3 | 166.24 Million CNY | -7.17% |
| 2013 Q1 | 199.08 Million CNY | -22.07% |
| 2013 Q2 | 179.07 Million CNY | -10.05% |
| 2012 Q2 | 157.29 Million CNY | -5.34% |
| 2012 FY | 745.36 Million CNY | 18.3% |
| 2012 Q1 | 166.16 Million CNY | -32.89% |
| 2012 Q3 | 166.45 Million CNY | 5.82% |
| 2012 Q4 | 255.45 Million CNY | 53.47% |
| 2011 FY | 630.09 Million CNY | 39.5% |
| 2011 Q4 | 247.6 Million CNY | 76.42% |
| 2011 Q1 | 120.81 Million CNY | -37.54% |
| 2011 Q2 | 121.32 Million CNY | 0.42% |
| 2011 Q3 | 140.35 Million CNY | 15.68% |
| 2010 Q4 | 193.43 Million CNY | 122.82% |
| 2010 Q2 | 96.43 Million CNY | 28.59% |
| 2010 FY | 451.67 Million CNY | 34.16% |
| 2010 Q1 | 74.99 Million CNY | -54.4% |
| 2010 Q3 | 86.81 Million CNY | -9.97% |
| 2009 Q3 | 50.35 Million CNY | -23.04% |
| 2009 FY | 336.65 Million CNY | 18.71% |
| 2009 Q4 | 164.45 Million CNY | 226.58% |
| 2009 Q1 | 56.4 Million CNY | 0.0% |
| 2009 Q2 | 65.43 Million CNY | 16.01% |
| 2008 FY | 283.58 Million CNY | 30.67% |
| 2007 FY | 217.02 Million CNY | 0.0% |